Published:
Psilocybe Subtropicalis
"Subtropical Psilocybe"
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeSubtropicalis_new-800x450.webp)
Scientific Classification
About
Psilocybe subtropicalis is a rare psilocybin-containing mushroom native to subtropical regions of Mexico and Central America. Known for its moderate psychoactive potency, it is closely related to Psilocybe mexicana and P. caerulescens, both of which have ceremonial and spiritual significance. Though less commonly discussed in mainstream mycology, it is appreciated for its smooth, introspective, and emotionally rich psychedelic experiences.
History
P. subtropicalis was originally classified as a variety of Psilocybe mexicana, but was later elevated to species level due to subtle morphological and ecological differences. It has historically been used by indigenous groups in Mexico during spiritual and healing ceremonies, particularly those involving visionary states or dreamwork.
While it lacks the fame of P. cubensis or P. azurescens, its role in Mesoamerican ethnomycology is respected, and it remains part of the region’s ancestral psychoactive fungal repertoire.
Overview
This species produces small, conic to bell-shaped fruiting bodies with caramel to reddish-brown caps that fade as they dry. The stems are slender and white, often bruising blue when handled, indicating the presence of psilocybin and psilocin. It grows on soil rich in organic debris, often in grasslands or near woodlands in humid, warm climates.
Effects are described as gentle but profound, offering emotional clarity, subtle visuals, and heightened introspection. It is typically consumed dried, and while it has not been widely cultivated, it is valued by ethnobotanists and psychonauts seeking ancestral mushroom experiences.
Physical Characteristics
Caps:
Conic to convex, with an obtuse umbo, hygrophanous, 2-5 cm wide, reddish-brown to yellowish-brown when moist, fading to pale ochre when dry
Gills:
Adnate to adnexed, initially pale, becoming purplish-black with age
Psychoactive Effects
Euphoric
Describing intense feelings of happiness or excitement
Perceptual
The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.
Spiritual
Subtropicalic has been said to sometimes facilite experiences that are deeply meaningful and transcendent
Pharmacology
Helps With
Depression
Relieves symptoms of depression, improving mood and outlook
Anxiety
Helps to alleviate feelings of worry, fear, and unease
Addiction
Helps to overcome addiction and substance abuse
PTSD
Helps to alleviate symptoms of post-traumatic stress disorder
OCD
Helps to alleviate symptoms of obsessive-compulsive disorder
ADD ADHD
Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder
Pain
Microdosing psilocybin has been shown to help with certain types of pain
Migraines
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Possible Side Effects
Nausea
A feeling of discomfort in the stomach with an urge to vomit
Grow at Home
Start your cultivation journey with quality grow kits from verified vendors
Chemical Constituents
Medicinal Chemistry
Similar Species
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeMexicana_new-400x400.webp)
Species: Psilocybe mexicana
Edibility: Psychoactive
Key Differences: P. mexicana typically has a more slender stem and a smaller, more conic cap compared to P. subtropicalis.
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeMexicana_new-400x400.webp)
Species: Psilocybe mexicana
Edibility: Psychoactive
Mushroom Ratings
4.0
(1)
Based on 1 Review
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
01/29/2025
Hunter Zyniecki
References
- Sekssaoui, M. (2024). Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?. .
- Ley, L. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. .
- Bae, S. (2023). Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. .
- Schindler, E. (2022 ). Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. .
- Barrett, F. (2022). Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. .
- Desai, S. (2022). Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study. .
- Rucker, J. (2021). Psilocybin: From Serendipity to Credibility?. .
- Schindler, E. (2021). Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. .
- Raval, N. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. .
- Kuypers, K. (2019). Psychedelic medicine: The biology underlying the persisting psychedelic effects. .